680 related articles for article (PubMed ID: 25809617)
21. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
[TBL] [Abstract][Full Text] [Related]
22. Daylight photodynamic therapy with methyl aminolevulinate cream is as effective as conventional photodynamic therapy with blue light in the treatment of actinic keratosis: a controlled randomized intra-individual study.
Assikar S; Labrunie A; Kerob D; Couraud A; Bédane C
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1730-1735. PubMed ID: 31955461
[TBL] [Abstract][Full Text] [Related]
23. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
[TBL] [Abstract][Full Text] [Related]
25. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
27. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
28. Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
García-Gil MF; Gracia-Cazaña T; Cerro-Muñoz P; Bernal-Masferrer L; Navarro-Bielsa A; Gilaberte Y
Dermatol Ther; 2022 Nov; 35(11):e15879. PubMed ID: 36184916
[TBL] [Abstract][Full Text] [Related]
29. A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Zane C; Fabiano A; Arisi M; Calzavara-Pinton P
Dermatology; 2016; 232(4):472-7. PubMed ID: 27578305
[TBL] [Abstract][Full Text] [Related]
30. Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
Fonda-Pascual P; Alegre-Sánchez A; Harto-Castaño A; Moreno-Arrones OM; Pérez-García B; González-Morales ML; Pindado-Ortega C; Gilaberte-Calzada Y; Aguilera J; Jaen-Olasolo P; Fernández-Guarino M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():136-141. PubMed ID: 30508663
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial.
Choi SH; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1598-605. PubMed ID: 25640401
[TBL] [Abstract][Full Text] [Related]
32. Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.
Zhu L; Wang P; Zhang G; Zhang L; Liu X; Hu C; Yang X; Sroka R; Zhou Z; Wang X
Photodiagnosis Photodyn Ther; 2018 Dec; 24():366-371. PubMed ID: 30336290
[TBL] [Abstract][Full Text] [Related]
33. Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Gilaberte Y; Aguilar M; Almagro M; Correia O; Guillén C; Harto A; Pérez-García B; Pérez-Pérez L; Redondo P; Sánchez-Carpintero I; Serra-Guillén C; Valladares LM
Actas Dermosifiliogr; 2015 Oct; 106(8):623-31. PubMed ID: 26115793
[TBL] [Abstract][Full Text] [Related]
34. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
[TBL] [Abstract][Full Text] [Related]
35. Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
Galimberti GN
Photodiagnosis Photodyn Ther; 2018 Mar; 21():172-175. PubMed ID: 29203353
[TBL] [Abstract][Full Text] [Related]
36. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
[TBL] [Abstract][Full Text] [Related]
37. Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Klein A; Karrer S; Horner C; Werner A; Heinlin J; Zeman F; Koller M; Landthaler M; Szeimies RM; Gruber M; Graf B; Hansen E; Kerscher C
Br J Dermatol; 2015 Jul; 173(1):192-200. PubMed ID: 25413485
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight protocol) compared with the conventional protocol involving irradiation with the Aktilite CL 128 lamp.
Vicentini C; Vignion-Dewalle AS; Thecua E; Lecomte F; Maire C; Deleporte P; Béhal H; Kerob D; Duhamel A; Mordon S; Mortier L
Br J Dermatol; 2019 Apr; 180(4):765-773. PubMed ID: 30367470
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
Eur J Dermatol; 2017 Feb; 27(1):89-91. PubMed ID: 27748261
[No Abstract] [Full Text] [Related]
40. A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial.
Torezan L; Grinblat B; Haedersdal M; Festa-Neto C; Szeimies RM
Eur J Dermatol; 2021 Oct; 31(5):638-644. PubMed ID: 34789450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
